There is evidence that changes in the gut microbiome may contribute to the development of obesity (84), with murine and human studies suggesting gut microbe-derived lipopolysaccharide and translocating gut bacteria may contribute to systemic inflammation in obesity (85–87), which can drive insulin resistance associated with the development of type 2 diabetes (88). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.